Average Co-Inventor Count = 3.00
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Race Oncology Ltd. (5 from 6 patents)
2. Urigen, Inc. (0 patent)
5 patents:
1. 11135201 - Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
2. 10548876 - Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
3. 10500192 - Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
4. 9993460 - Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof
5. 9974774 - Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof